Literature DB >> 19217814

The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations.

Cheryl R Greenberg1, Louise A Dilling, G Robert Thompson, Lorne E Seargeant, James C Haworth, Susan Phillips, Alicia Chan, Hilary D Vallance, Paula J Waters, Graham Sinclair, Yolanda Lillquist, Ronald J A Wanders, Simon E Olpin.   

Abstract

Investigation of seven patients from three families suspected of a fatty acid oxidation defect showed mean CPT-I enzyme activity of 5.9+/-4.9 percent of normal controls. The families, two Inuit, one First Nation, live in areas of Canada geographically very distant from each other. The CPT1 and CPT2 genes were fully sequenced in 5 of the patients. All were homozygous for the same P479L mutation in a highly conserved region of the CPT1 gene. Two patients from the first family were also homozygous for the CPT2 F352C polymorphism in the CPT2 gene. Genotyping the patients and their family members confirmed that all seven patients were homozygous for the P479L variant allele in the CPT1 gene, as were 27 of 32 family members. Three of the seven patients and two cousins had hypoketotic hypoglycemia attributable to CPT-Ia deficiency, but adults homozygous for the variant denied hypoglycemia. We screened 422 consecutive newborns from the region of one of the Inuit families for this variant; 294 were homozygous, 103 heterozygous, and only 25 homozygous normal; thus the frequency of this variant allele is 0.81. There was an infant death in one family and at least 10 more deaths in those infants (7 homozygous, 3 heterozygous) consecutively tested for the mutation at birth. Thus there is an astonishingly high frequency of CPT1 P479L variant and, judging from the enzyme analysis in the seven patients, also CPT-I deficiency in the areas of Canada inhabited by these families. Despite the deficiency of CPT-Ia which is the major rate-limiting enzyme for long chain fatty acid oxidation, clinical effects, with few exceptions, were slight or absent. One clue to explaining this paradox is that, judging from the fatty acid oxidation studies in whole blood and fibroblasts, the low residual activity of CPT-Ia is sufficient to allow a reasonable flux through the mitochondrial oxidation system. It is likely that the P479L variant is of ancient origin and presumably its preservation must have conveyed some advantage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217814     DOI: 10.1016/j.ymgme.2008.12.018

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  25 in total

1.  Recurrent exercise-induced rhabdomyolysis.

Authors:  Fady Hannah-Shmouni; Kevin McLeod; Sandra Sirrs
Journal:  CMAJ       Date:  2012-02-06       Impact factor: 8.262

2.  Cholestatic Jaundice Associated with Carnitine Palmitoyltransferase IA Deficiency.

Authors:  A A M Morris; S E Olpin; M J Bennett; A Santani; J Stahlschmidt; P McClean
Journal:  JIMD Rep       Date:  2012-03-21

Review 3.  Hunter-gatherer genomics: evolutionary insights and ethical considerations.

Authors:  Richard J Bankoff; George H Perry
Journal:  Curr Opin Genet Dev       Date:  2016-07-09       Impact factor: 5.578

4.  Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant.

Authors:  Melanie B Gillingham; Matthew Hirschfeld; Sarah Lowe; Dietrich Matern; James Shoemaker; William E Lambert; David M Koeller
Journal:  Mol Genet Metab       Date:  2011-06-28       Impact factor: 4.797

5.  Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos.

Authors:  Dominick J Lemas; Howard W Wiener; Diane M O'Brien; Scarlett Hopkins; Kimber L Stanhope; Peter J Havel; David B Allison; Jose R Fernandez; Hemant K Tiwari; Bert B Boyer
Journal:  J Lipid Res       Date:  2011-11-01       Impact factor: 5.922

6.  PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation.

Authors:  Lu Tan; Srinivas B Narayan; Jie Chen; Gail Ditewig Meyers; Michael J Bennett
Journal:  J Inherit Metab Dis       Date:  2011-01-21       Impact factor: 4.982

Review 7.  The Genetic Basis of Metabolic Disease.

Authors:  Inês Barroso; Mark I McCarthy
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

Review 8.  Pathophysiology of fatty acid oxidation disorders.

Authors:  M J Bennett
Journal:  J Inherit Metab Dis       Date:  2009-10-10       Impact factor: 4.982

9.  Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency.

Authors:  Jong Sub Choi; Hyeoh Won Yoo; Kyung Jae Lee; Jung Min Ko; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-03-22

10.  Inborn Errors of Metabolism in the United Arab Emirates: Disorders Detected by Newborn Screening (2011-2014).

Authors:  Fatma A Al-Jasmi; Aisha Al-Shamsi; Jozef L Hertecant; Sania M Al-Hamad; Abdul-Kader Souid
Journal:  JIMD Rep       Date:  2015-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.